Related references
Note: Only part of the references are listed.Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016)
Maroula G. Kokotou et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples
Christopher Dietz et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2017)
Structural verification via convergent total synthesis of dipeptide-lipids isolated from Porphyromonas gingivalis
Christopher Dietz et al.
TETRAHEDRON (2016)
Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line
Kah Yan How et al.
FRONTIERS IN MICROBIOLOGY (2016)
Serine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2
Yu-Hsiung Wang et al.
BONE (2015)
Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein-Associated Phospholipase A2
Robert S. Fenning et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Lipoprotein lipase and atherosclerosis
Junji Kobayashi et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2015)
Cytosolic Phospholipase A2 Modulates TLR2 Signaling in Synoviocytes
Randi M. Sommerfelt et al.
PLOS ONE (2015)
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
Harvey D. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis
Zahra Armingohar et al.
JOURNAL OF ORAL MICROBIOLOGY (2014)
Serine Lipids of Porphyromonas gingivalis Are Human and Mouse Toll-Like Receptor 2 Ligands
Robert B. Clark et al.
INFECTION AND IMMUNITY (2013)
Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis
Vahid Farrokhi et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2013)
Phospholipase A2 enzymes and the risk of atherosclerosis
Robert S. Rosenson et al.
EUROPEAN HEART JOURNAL (2012)
Toll-like Receptor Signaling Pathways in Cardiovascular Diseases: Challenges and Opportunities
Faezeh Moghimpour Bijani et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
Linda K. Curtiss et al.
JOURNAL OF LIPID RESEARCH (2012)
Coordinate Regulation of TLR-Mediated Arachidonic Acid Mobilization in Macrophages by Group IVA and Group V Phospholipase A2S
Violeta Ruiperez et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR2 ligands augment cPLA2α activity and lead to enhanced leukotriene release in human monocytes
Sabine C. Lindner et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Emerging role of Toll-like receptors in atherosclerosis
Linda K. Curtiss et al.
JOURNAL OF LIPID RESEARCH (2009)
Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings
Monika Madan et al.
PLOS ONE (2008)
Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: Disparate diseases with commonalities in pathogenesis through TLRs
Frank C. Gibson et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
Frank D. Kolodgie et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Secretory phospholipase A2 of group IIA:: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
M Menschikowski et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Diversity of the human intestinal microbial flora
PB Eckburg et al.
SCIENCE (2005)
Identification of periodontal pathogens in atherosclerotic vessels
NE Fiehn et al.
JOURNAL OF PERIODONTOLOGY (2005)
Secondary prevention of atherosclerosis through Chlamydia pneumoniae eradication (SPACE trial):: A randomised clinical trial in patients with peripheral arterial disease
T Vainas et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2005)
Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis
FC Nichols et al.
JOURNAL OF LIPID RESEARCH (2004)
Porphyromonas gingivalis induces murine macrophage foam cell formation
MS Qi et al.
MICROBIAL PATHOGENESIS (2003)
Antibiotic treatment of atherosclerosis
JB Muhlestein
CURRENT OPINION IN LIPIDOLOGY (2003)
Detection of Porphyromonas gingivalis DNA in aortic tissue by PCR
M Stelzel et al.
JOURNAL OF PERIODONTOLOGY (2002)
Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques
JD Laman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum
K Gomi et al.
JOURNAL OF IMMUNOLOGY (2002)
Lipoprotein lipase in the arterial wall -: Linking LDL to the arterial extracellular matrix and much more
MO Pentikäinen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Identification of periodontal pathogens in atheromatous plaques
VI Haraszthy et al.
JOURNAL OF PERIODONTOLOGY (2000)
Share Paper
